To cite this paper use one of the standards below:
Introduction - Age-related changes in the immune system can affect the occurrence and clinical expression of autoimmune disorders. While some studies have explored neuromyelitis optica spectrum disorder (NMOSD) in older adults, analysis of "very late-onset NMOSD" (VLO-NMOSD), with onset at 70 years or older, remains limited to case. Objective - To assess the frequency, clinical characteristics, and outcomes of VLO-NMOSD patients in a large Latin American (LATAM) NMOSD cohort. Methods – The study included NMOSD patients meeting the 2015 IPND criteria from nine LATAM countries. Patients were categorized into VLO-NMOSD (≥70 years) and Non-VLO-NMOSD groups. We the demographic and clinical features of VLO-NMOSD with NMOSD onset at <70 years (Non-VLO-NMOSD). Results – Out of 1185 NMOSD patients, data on age at onset were available for 1179, with 14 (1.2%) in the VLO-NMOSD group. For these 14 patients the median age was 73 [71 - 83], 12 (85.7) were female, the most common presenting symptoms were myelitis and optic neuritis [10 and 7], and median disease duration was 40.9 [9.0 – 149.0]. The median ARR was 0.37, and the median EDSS score was 6.0 ( 5.0 - 7.5). Compared to Non-VLO-NMOSD, VLO-NMOSD had a higher proportion of females and patients with mixed race/ethnicity, fewer Caucasians, more myelitis and optic neuritis (71.4% vs.48.1%, 50% vs 48.1%). None of the VLO-NMOSD cases presented with area postrema, cerebral, or diencephalic syndromes. VLO-NMOSD had a lower ARR (0.37) and higher EDSS scores (p=0.004). Differences in other characteristics between the groups did not reach statistical significance. Conclusion - VLO-NMOSD is rare and demonstrates unique clinical characteristics with more severe outcomes. Notably, VLO-NMOSD in LATAM presents with optic neuritis more frequently at onset compared to other population series.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper